🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

12444+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 12444 recruiting trials

Phase 3RecruitingNCT06702124

A Phase 3 Study of Rotigotine in Combination with Rivastigmine in Mild to Moderate Alzheimer's Disease

🏥 I.R.C.C.S. Fondazione Santa Lucia📍 1 site📅 Started Dec 2023View details ↗
Phase 2RecruitingNCT07266493

Efficacy and Safety of Neoadjuvant Envafolimab Combined With Albumin-bound Paclitaxel and Carboplatin for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma

🏥 Shanghai Zhongshan Hospital📍 1 site📅 Started Dec 2023View details ↗
NARecruitingNCT06472505

Using Polyglycolic Acid Mesh Prevents Cerebrospinal Fluid Leakage

👨‍⚕️ Abel Huang, MD, National Taiwan University Hospital📍 1 site📅 Started Dec 2023View details ↗
RecruitingNCT06190834

Relationship Between High-Density Lipoprotein Subtypes and Coronary Heart Disease Prognosis.

👨‍⚕️ Yu Geng, Beijing Tsinghua Changgeng Hospital📍 1 site📅 Started Dec 2023View details ↗
Phase 2RecruitingNCT06094881

A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Pediatric Primary Immune Thrombocytopenia (ITP)

👨‍⚕️ Lei Zhang, MD, Chinese Academy of Medical Science and Blood Disease Hospital📍 1 site📅 Started Dec 2023View details ↗
RecruitingNCT06299748

A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.

🏥 argenx📍 4 sites📅 Started Nov 2023View details ↗
Phase 2RecruitingNCT06876688

Relma-cel Followed by Tislelizumab for the Treatment of Relapsed/Refractory CNS Large B-Cell Lymphoma

🏥 Ruijin Hospital📍 6 sites📅 Started Nov 2023View details ↗
RecruitingNCT05702645

A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia

👨‍⚕️ Maria M Gramatges, Children's Oncology Group📍 70 sites📅 Started Nov 2023View details ↗
NARecruitingNCT06182748

Physical Activity and Fibrosing Interstitial Lung Disease

🏥 Assistance Publique - Hôpitaux de Paris📍 1 site📅 Started Nov 2023View details ↗
Phase 1RecruitingNCT06010875

A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors

👨‍⚕️ Fei Li, M.D, The First Affiliated Hospital of Nanchang University📍 1 site📅 Started Nov 2023View details ↗
Phase 1, PHASE2RecruitingNCT06066359

Phase I/II Trial of Cord Blood-Derived NK Cells Genetically Engineered With NY-ESO-1 TCR/IL-15 Cell Receptor for Relapsed/Refractory Multiple Myeloma

👨‍⚕️ Muzaffar Qazilbash, M D, M.D. Anderson Cancer Center📍 1 site📅 Started Nov 2023View details ↗
Phase 2RecruitingNCT05872204

Abemaciclib and Letrozole in Patients With Estrogen Receptor-positive Rare Ovarian Cancer

👨‍⚕️ Els Van Nieuwenhuysen, MD PhD, UZ Leuven📍 12 sites📅 Started Nov 2023View details ↗
Phase 2RecruitingNCT05004064

Acalabrutinib and Rituximab in Previously Untreated Mantle Cell Lymphoma

👨‍⚕️ Toby Eyre, Churchill Hospital, Oxford, United Kingdom📍 12 sites📅 Started Nov 2023View details ↗
NARecruitingNCT06848608

Comparison of the Effects of Yoga and Conventional Physiotherapy Programs in Sarcoidosis

👨‍⚕️ Zuhal D TAKİNACI, PT, Asst Prof, University of Health science📍 1 site📅 Started Nov 2023View details ↗
Phase 3RecruitingNCT05712694

Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC)

👨‍⚕️ John S Bomalaski, Polaris Group📍 30 sites📅 Started Nov 2023View details ↗
RecruitingNCT05406037

Biomarkers for Invasive Mucormycosis

👨‍⚕️ Marjorie CORNU, MD, University Hospital, Lille📍 1 site📅 Started Nov 2023View details ↗
NARecruitingNCT06592404

The (Cost)Effectiveness of a Social Robot for Persons with Problems in Daily Structure and Planning in Disability Care

👨‍⚕️ Brigitte JF Boon, Prof. Dr., Academy Het Dorp, Arnhem, The Netherlands📍 3 sites📅 Started Nov 2023View details ↗
Phase 2RecruitingNCT05762536

Docetaxel or Cabazitaxel With or Without Darolutamide in mCRPC

🏥 Erasmus Medical Center📍 1 site📅 Started Nov 2023View details ↗
Phase 3RecruitingNCT06083129

Phase III Study Comparing GVHD Prophylaxis With ATG-thymoglobulin to ATLG-grafalon in Elderly Patients With Acute Myeloid Leukemia or Myelodysplasic Syndrome and Receiving an Allogeneic Hematopoietic Stem Cell Transplantation With a 10/10 HLA Matched Unrelated Donor

🏥 Assistance Publique - Hôpitaux de Paris📍 28 sites📅 Started Nov 2023View details ↗
NARecruitingNCT05733910

Simultaneous Integrated Boost in Carbon Ion Radiotherapy for Head and Neck Adenoid Cystic Carcinoma

👨‍⚕️ Sara Ronchi, MD, CNAO National Center of Oncological Hadrontherapy📍 1 site📅 Started Nov 2023View details ↗
← PreviousPage 355 of 623Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →